Medicine & Health

The first sickle cell disease patient in the St. Louis region has been successfully treated by WashU Medicine physicians at St. Louis Children’s Hospital with a gene therapy newly approved by the Food and Drug Administration.

The National Institutes of Health (NIH) has awarded David M. Ornitz, MD, PhD, of WashU Medicine, $740,000 annually for four years to support research aimed at understanding respiratory complications associated with premature birth.

An interdisciplinary research team at Washington University in St. Louis has found that variability in sleep patterns in people experiencing pregnancy can effectively predict preterm birth.

Fixing problems with cholesterol metabolism might help slow or prevent age-related macular degeneration, a leading cause of blindness in older adults, a new WashU Medicine study in mice has shown.

Occupational therapy faculty member Kelly Harris, at WashU Medicine, will receive a $425,000 award to develop and test a technology-enabled care coordination service model to support Black youth with asthma.

Biologist Keith Hengen in Arts & Sciences at Washington University in St. Louis says “criticality” is the key to understanding how the brain works — and how to keep it free from Alzheimer’s and other diseases.

The FDA has given market authorization to a WashU startup’s technology that quickly and accurately maps the sensitive areas in patients’ brains to help neurosurgeons plan safe and effective surgeries.

WashU public health experts are leading a $3 million global initiative to revolutionize health research, making it faster, more inclusive and more responsive to urgent policy challenges.

Researchers at Washington University in St. Louis are using machine learning to better predict who will experience persistent pain after surgery.

WashU Medicine neurosurgeon Dimitrios Mathios, MD, has developed a liquid biopsy that is aided by machine-learning tools to improve the detection of brain cancers.